You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Understanding ZEJULA

The following videos provide further insight into the unmet need of ovarian cancer, trial design and efficacy of the PRIMA trial, and safety and dosing information for ZEJULA. View them now to learn more about ZEJULA and why it may be the right choice for your ovarian cancer patients.

Now Playing
1: OC Unmet Need & PARPi MOA
Now Playing
2: Trial Design & Efficacy
Now Playing
3: Safety
Now Playing
4: Dosing


See the PRIMA clinical trial design

View Trial Info
ZEJULA (niraparib) Dosing Information


See recommendations for dose adjustments

Review Dosing
Back to Top